BSE benchmark Sensex plummeted 778 points to close below the 55,500-level on Wednesday following a broad-based selloff in global markets as the Russia-Ukraine crisis escalated. The 30-share BSE index ended 778.38 points or 1.38 per cent lower at 55,468.90. Similarly, the NSE Nifty plunged 187.95 points or 1.12 per cent to 16,605.95.
Markets continued to fall on Monday, with the Sensex declining 94 points as investors remained cautious amid unabated selling by foreign funds and elevated crude oil prices ahead of the RBI's policy decision later this week. The 30-share BSE Sensex declined 93.91 points or 0.17 per cent to end at 55,675.32. During the day, it tanked 473.49 points or 0.84 per cent to 55,295.74.
The Drugs Controller General of India will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India.
Equity benchmarks bounced back sharply on Friday after facing a heavy drubbing in the previous trade, with the Sensex and Nifty jumping nearly 3 per cent, aided by positive trends from global markets and across-the-board buying. Index majors Reliance Industries and HDFC twins saw robust buying, helping the benchmarks. The 30-share BSE Sensex rallied 1,534.16 points or 2.91 per cent to settle at 54,326.39.
Delhi Capitals have never won the IPL despite featuring top talent over the years. Under Axar Patel's leadership, they will hope IPL 2025 finally ends their title drought.
ICICI Bank was the top gainer in the Sensex pack, soaring nearly 11 per cent, followed by Axis Bank, Dr Reddy's, SBI, M&M and Tech Mahindra. NSE Nifty advanced 10.50 points to 18,125.40.
SBI was the top gainer in the Sensex pack, advancing over 2 per cent, followed by L&T, ITC, Dr Reddy's, Axis Bank and PowerGrid. NSE Nifty rose 22.40 points to 15,197.70.
Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?
There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies. Outlining the sector's wish list for the upcoming Union Budget, Organisation of Pharmaceutical Producers of India (OPPI) Director General Anil Matai urged the government to explore methods to incentivise R&D investments, such as deductions on R&D expenses, research-linked incentives for MNCs, and corporate tax concessions.
Benchmark BSE Sensex rallied over 350 points on Tuesday following gains in index majors HDFC twins, Bharti Airtel and Infosys amid a largely positive trend in global equity markets. The 30-share BSE barometer jumped 350.16 points or 0.61 per cent to settle at 57,943.65. During the day, it rallied 408.04 points or 0.70 per cent to 58,001.53. The broader NSE Nifty gained 103.30 points or 0.60 per cent to settle at 17,325.30.
Bajaj Finserv was the top loser in the Sensex pack, shedding 4.57 per cent, followed by Infosys, TCS, Sun Pharma, HCL Tech, HUL, Dr Reddy's, HDFC and Reliance Industries. NSE Nifty plunged 181.40 points to 17,757.00.
Equity benchmarks Sensex and Nifty on Thursday gave up all early gains to settle lower as surging oil prices amid the ongoing conflict between Russia and Ukraine hit investor sentiment. The 30-share BSE Sensex started the trade on a higher note and jumped 527.72 points in morning deals to a high of 55,996.62. However, during the afternoon trade it surrendered all its early gains and finished at 55,102.68, lower by 366.22 points or 0.66 per cent.
A reading of the reports suggests that there is no standard practice for reporting political contributions and it is left to the company's discretion to report them as they find fit.
Tata Steel was the top loser in the Sensex pack, plunging over 8 per cent, followed by SBI, Dr Reddy's, Kotak Bank, Sun Pharma, Bajaj Auto and L&T. NSE Nifty declined 118.35 points or 0.71 per cent to 16,450.50.
M&M was the top gainer in the Sensex pack, rising over 2 per cent, followed by Axis Bank, Tech Mahindra, Bajaj Finserv, IndusInd Bank, Titan and Dr Reddy's. NSE Nifty advanced 20.05 points to 16,258.25.
Kotak Bank was the top loser in the Sensex pack, shedding over 2 per cent, followed by Dr Reddy's, M&M, PowerGrid, NTPC, Nestle India and HDFC Bank. NSE Nifty slipped 37.05 points to 15,709.40.
The firm presented that Sputnik Light vaccine is approved in 29 countries, including Russia and Argentina.
NTPC was the top gainer in the Sensex pack, rising around 4 per cent, followed by Bajaj Finserv, SBI, Bajaj Finance, Tech Mahindra, Dr Reddy's and Tata Steel.
Bajaj Finserv was the top loser in the Sensex pack, shedding over 2 per cent, followed by Infosys, Tech Mahindra, UltraTech Cement and IndusInd Bank. On the other hand, Dr Reddy's, Bajaj Auto, Sun Pharma, Asian Paints and NTPC were among the gainers. NSE Nifty lost 41.50 points to end at 15,680.
According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.
IndusInd Bank was the top gainer in the Sensex pack, soaring over 7 per cent, followed by Bharti Airtel, HCL Tech, Tata Steel, Tech Mahindra and Dr Reddy's.
NTPC was the top loser in the Sensex pack, shedding around 3 per cent, followed by M&M, Axis Bank, PowerGrid, Kotak Bank, Dr Reddy's, Bajaj Finserv and HDFC.
Private hospital chains Fortis Healthcare and Apollo Hospitals have started administering Russian COVID-19 vaccine Sputnik V at two of their hospitals in Delhi-NCR, officials said.
Equity benchmark indices ended lower on Thursday in line with weak global market trends. The 30-share BSE Sensex declined 230.12 points or 0.37 per cent to settle at 61,750.60. During the day, it fell 337.45 points or 0.54 per cent to 61,643.27.
The Hyderabad-based AIG Hospitals recently published a study conducted on 260 healthcare workers, who got vaccinated between January 16 and February 5, in the International Journal of Infectious Diseases (a peer-reviewed journal).
Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.
Titan, Maruti Suzuki India, Asian Paints, Mahindra & Mahindra and Hindustan Unilever Limited were the biggest drags on the Sensex, tumbling up to 5.05 per cent. In contrast, ITC, Dr Reddy's Laboratories, Tech Mahindra and UltraTech Cement were among the gainers.
Only in the event of the RSS managing to force Modi into accepting a consensual candidate, will the party not continue to 'being' the 'next Congress', observes Nilanjan Mukhopadhyay.
Jimmy Carter, the 39th president of the United States, was the third American leader to visit India during which a village in Haryana was named Carterpuri in his honour.
Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and amortisation) margins are anticipated to improve by about 110 basis points. Ebitda improvement will be led by lower input costs because prices of active pharmaceutical ingredients (APIs) are 5-15 per cent lower year-on-year (Y-o-Y). Axis Capital said sales growth would be around 10 per cent, of which growth in the India market would be 11 per cent or so.
Tata Steel was the top loser in the Sensex pack, sinking nearly 10 per cent, followed by SBI, IndusInd Bank, HDFC, Dr Reddy's and M&M. NSE Nifty tumbled 188.25 points to 17,396.90.
Equity benchmarks ended higher on Wednesday amid buying in banking counters and a firm trend in global markets. Continuing its previous day rally, the 30-share BSE Sensex climbed 91.62 points or 0.15 per cent to settle at 61,510.58. During the day, it jumped 361.94 points or 0.58 per cent to 61,780.90. The broader NSE Nifty gained 23.05 points or 0.13 per cent to end at 18,267.25.
The mortal remains of former prime minister Dr Manmohan Singh were consigned to flames at the Nigambodh Ghat in New Delhi on Saturday amid the chanting of religious hymns. The funeral pyre was lit by his eldest daughter Upinder Singh.
TCS was the top gainer in the Sensex pack, rising over 3 per cent, followed by HUL, UltraTech Cement, Nestle India, Kotak Bank, Dr Reddy's and Titan. NSE Nifty surged 157.90 points to 17,234.15.
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation
Asian Paints was the top gainer in the Sensex pack, rising 4 per cent, followed by Sun Pharma, HUL, HDFC, Dr Reddy's, Nestle India and M&M. NSE Nifty advanced 45.70 points to 14,683.50.
Tech Mahindra was the top gainer in the Sensex pack, rising over 3 per cent, followed by Dr Reddy's, PowerGrid, Kotak Bank, Sun Pharma, ICICI Bank and M&M. On the other hand, IndusInd Bank, Asian Paints, Maruti and Bharti Airtel were among the laggards.
Benchmark indices ended in the green on Friday after falling for the past two days, helped by continuous buying from foreign institutional investors and a largely positive trend in Asian and European markets. The 30-share BSE Sensex climbed 113.95 points or 0.19 per cent to settle at 60,950.36. Similarly, the broader NSE Nifty ended 64.45 points or 0.36 per cent higher at 18,117.15.
Benchmark indices maintained their winning momentum for the fourth day running on Tuesday, helped by a rally in Asian and European markets and continuous foreign fund inflows. The 30-share BSE Sensex climbed 374.76 points or 0.62 per cent to settle at 61,121.35. During the day, it jumped 543.14 points or 0.89 per cent to 61,289.73.
The most important finding of the study was that the Spike-protein neutralising antibodies found in the mixed vaccine groups were significantly higher than the same-vaccine groups, D Nageshwar Reddy, Chairman of AIG Hospitals said.
